Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression: (Consensus Statement)
Open accessThe DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To provide expert recommendations for the safe and effective application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder (MDD). PARTICIPANTS: Participants included a group of 17 expert clinicians and researchers with expertise in the clinical application of rTMS, representing both the National Network of Depression Centers (NNDC) rTMS Task Group and the American Psychiatric Association Council on Research (APA CoR) Task Force on Novel Biomarkers and Treatments. EVIDENCE: The consensus statement is based on a review of extensive literature from 2 databases (OvidSP MEDLINE and PsycINFO) searched from 1990 through 2016. The search terms included variants of major depressive disorder and transcranial magnetic stimulation. The results were limited to articles written in English that focused on adult populations. Of the approximately 1,500 retrieved studies, a total of 118 publications were included in the consensus statement and were supplemented with expert opinion to achieve consensus recommendations on key issues surrounding the administration of rTMS for MDD in clinical practice settings. CONSENSUS PROCESS: In cases in which the research evidence was equivocal or unclear, a consensus decision on how rTMS should be administered was reached by the authors of this article and is denoted in the article as "expert opinion." CONCLUSIONS: Multiple randomized controlled trials and published literature have supported the safety and efficacy of rTMS antidepressant therapy. These consensus recommendations, developed by the NNDC rTMS Task Group and APA CoR Task Force on Novel Biomarkers and Treatments, provide comprehensive information for the safe and effective clinical application of rTMS in the treatment of MDD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repetitive transcranial magnetic stimulation (rTMS) is an effective method used in clinical practice for treating patients with MDD. 408”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [408]
In the citing paper
“Most clinical rTMS treatments for MDD occur daily (one rTMS session per day) and are applied using scalp-based targeting of DLPFC. These standard treatments are only modestly effective, even in the general MDD population (17, 24–31).”
In the citing paper
“rTMS of the left side of the dorsolateral prefrontal cortex (DLPFC) at 10 Hz is a well-tolerated, evidence-based treatment for TRD.5”
In the citing paper
“While this intensity is consistent with current recommendations for standard rTMS,5 there is no current consensus on the optimal intensity for TBS and other studies have used lower intensities.12”
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Rossi, S., Hallett, M., Rossini, P. M., & Pascual-Leone, A. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.08.016 · Cited by 5,367
NON-INVASIVE MAGNETIC STIMULATION OF HUMAN MOTOR CORTEX
Barker, A. T., Jalinous, R., & Freeston, I. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92413-4 · Cited by 4,460
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Wassermann, E. M. (1998) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/s0168-5597(97)00096-8 · Cited by 2,293
Lefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
O’Reardon, J. P., Solvason, H. B., Janicak, P. G., Sampson, S., Isenberg, K. E., Nahas, Z., McDonald, W. M., Avery, D., Fitzgerald, P. B., Loo, C., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.018 · Cited by 1,910
Self-citationUsing the International 10-20 EEG System for Positioning of Transcranial Magnetic Stimulation
Herwig, U., Satrapi, P., & Schönfeldt-Lecuona, C. (2003) · Brain Topography · doi:10.1023/b:brat.0000006333.93597.9d · Cited by 1,098
George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092 · cited 1×
“…magnetic stimulation device package insert as well as in the US Food and Drug Administration (FDA) 510k application material. b In the study by George et al,10 patients underwent head magnetic resonance imaging with fiducials (vitamin E capsules), which resulted in 33.2% of patients having…”
BackgroundInfluentialSelf-citation
Cited by
Blumberger, D. M., Vila-Rodriguez, F., Thorpe, K. E., Feffer, K., Noda, Y., Giacobbe, P., Knyahnytska, Y., Kennedy, S. H., Lam, R. W., Daskalakis, Z. J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30295-2 · Cited by 1,363
Perinatal mental health: a review of progress and challenges
Howard, L. M., & Khalifeh, H. (2020) · World Psychiatry · doi:10.1002/wps.20769 · Cited by 1,118
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
Malhi, G. S., Bell, E., Bassett, D., Boyce, P., Bryant, R., Hazell, P., Hopwood, M., Lyndon, B., Mulder, R., Porter, R., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420979353 · Cited by 614
“…unipolar and bipolar depression that has failed to respond adequate pharmacological management (Berlim et al., 2014; Brunoni et al., 2017; Garnaat et al., 2018; Hovington et al., 2013; Kedzior et al., 2015; McClintock et al., 2018; Milev et al., 2016; Mutz et al., 2018, 2019; Perera et al., 2016).”
BackgroundResultInfluentialWeigand, A., Horn, A., Caballero, R., Cooke, D., Stern, A. P., Taylor, S. F., Press, D., Pascual-Leone, A., & Fox, M. D. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.028 · Cited by 487
“Recent consensus guidelines recommend targeting based on the electroencephalography F3 coordinate, which may better account for head size (31,33,34).”
Self-citationUsing brain imaging to improve spatial targeting of transcranial magnetic stimulation for depression
Cash, R. F. H., Weigand, A., Zalesky, A., Siddiqi, S. H., Downar, J., Fitzgerald, P. B., & Fox, M. D. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.05.033 · Cited by 366
“This approach has seen widespread clinical implementation, is located with high reliability (51), and is endorsed by the Clinical TMS Society (52).”
BackgroundNon-invasive transcranial ultrasound stimulation for neuromodulation
Darmani, G., Bergmann, T. O., Butts Pauly, K., Caskey, C. F., de Lecea, L., Fomenko, A., Fouragnan, E., Legon, W., Murphy, K. R., Nandi, T., et al. (2022) · Clinical Neurophysiology · doi:10.1016/j.clinph.2021.12.010 · Cited by 332
Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Li, Z., Ruan, M., Chen, J., & Fang, Y. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00638-3 · Cited by 326
“meta-analysis studies has shown that rTMS can treat depressive patients with safety [154].”
BackgroundElyamany, O., Leicht, G., Herrmann, C. S., & Mulert, C. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01209-9 · Cited by 310
Accelerated TMS for Depression: A systematic review and meta-analysis
Sonmez, A. I., Camsari, D. D., Nandakumar, A. L., Voort, J. L. V., Kung, S., Lewis, C. P., & Croarkin, P. E. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.041 · Cited by 255
“In this open-label study, researchers provided a 2-week HF-rTMS protocol involving 6800 pulses/day in once-daily sessions (compared to approximately 3000 pulses/day in conventional HF-rTMS protocols) to 19 patients with treatment-resistant MDD. 33% of patients met criteria for clinical remission at the conclusion of t…”
BackgroundInfluentialState-dependent effects of neural stimulation on brain function and cognition
Bradley, C., Nydam, A. S., Dux, P. E., & Mattingley, J. B. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-022-00598-1 · Cited by 238
Depression and Heart Failure: The Lonely Comorbidity
Sbolli, M., Fiuzat, M., Cani, D., & O’Connor, C. M. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1865 · Cited by 232
Sackeim, H. A., Aaronson, S. T., Carpenter, L. L., Hutton, T. M., Mina, M., Pages, K., Verdoliva, S., & West, W. S. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.08.005 · Cited by 201
Self-citationCash, R. F. H., Cocchi, L., Lv, J., Wu, Y., Fitzgerald, P. B., & Zalesky, A. (2021) · Human Brain Mapping · doi:10.1002/hbm.25330 · Cited by 194
“The cost of fMRI also appears reasonable when considering for the total cost of TMS treatment (McClintock et al., 2018).”
BackgroundTrajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study
Kaster, T. S., Downar, J., Vila-Rodriguez, F., Thorpe, K. E., Feffer, K., Noda, Y., Giacobbe, P., Knyahnytska, Y., Kennedy, S. H., Lam, R. W., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18091096 · Cited by 168
An Overview of Noninvasive Brain Stimulation: Basic Principles and Clinical Applications
Bhattacharya, A., Kambhampati, M., Sreepada, S. S. S., Sathyaprabha, T. N., Pal, P. K., Chen, R. E., & Udupa, K. (2021) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2021.158 · Cited by 189
“Syncope is another potential side-effects of rTMS especially in patients with high degree of anxiety, dehydration, or hypoglycemia.(46) Figure 2: Schematic representation of the transcranial magnetic stimulation demonstrating the magnetic field generated with the magnetic coil placed over the hand area of the primary…”
BackgroundA systematic review and meta-analysis of neuromodulation therapies for substance use disorders
Mehta, D. D., Praecht, A., Ward, H. B., Sanches, M., Sorkhou, M., Tang, V. M., Steele, V. R., Hanlon, C. A., & George, T. P. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01776-0 · Cited by 191
“Notably, the mPFC/frontal pole (with or without concurrent stimulation of ACC) emerged as a novel therapeutic target, particularly with a deep TMS protocol with H-coil technology, as indicated by studies with alcohol [63, 68] and cocaine [91].”
BackgroundDiagnosis and management of bipolar disorders
Goes, F. S. (2023) · BMJ · doi:10.1136/bmj-2022-073591 · Cited by 201
Blumberger, D. M., Mulsant, B. H., Thorpe, K. E., McClintock, S. M., Konstantinou, G. N., Lee, H. H., Nestor, S. M., Noda, Y., Rajji, T. K., Trevizol, A. P., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.2862 · Cited by 142
Self-citationTranscranial Magnetic Stimulation (TMS) Safety with Respect to Seizures: A Literature Review
Stultz, D. J., Osburn, S., Burns, T., Pawlowska-Wajswol, S., & Walton, R. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s276635 · Cited by 139
Croarkin, P. E., Elmaadawi, A. Z., Aaronson, S. T., Schrodt, G. R., Holbert, R. C., Verdoliva, S., Heart, K. L., Demitrack, M. A., & Strawn, J. R. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00829-y · Cited by 144
Transcranial Magnetic Stimulation in the Treatment of Neurological Diseases
Somaa, F. A., de Graaf, T. A., & Sack, A. T. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.793253 · Cited by 161
“There are other currently applied rTMS treatments in neurology, for instance in the acute treatment of migraine and migraine prevention, non-motor stroke, other CNS pain syndromes, and H-coil deep TMS for poststroke aphasia (6, 25, 26).”
MethodSchulze, L., Feffer, K., Lozano, C. S., Giacobbe, P., Daskalakis, Z. J., Blumberger, D. M., & Downar, J. H. (2017) · Brain stimulation · doi:10.1016/j.brs.2017.11.002 · Cited by 133
Treatments to Promote Neural Repair after Stroke
Cramer, S. C. (2018) · Journal of Stroke · doi:10.5853/jos.2017.02796 · Cited by 154
Hunter, A. M., Minzenberg, M., Cook, I. A., Krantz, D. E., Levitt, J. G., Rotstein, N. M., Chawla, S. A., & Leuchter, A. F. (2019) · Brain and Behavior · doi:10.1002/brb3.1275 · Cited by 136
Self-citationBaeken, C., Brem, A., Arns, M., Brunoni, A. R., Filipčić, I., Ganho-Ávila, A., Langguth, B., Padberg, F., Poulet, E., Rachid, F., et al. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000533 · Cited by 144
“criterion to define the optimal brain target keeps the uncertainty around the clinical relevance of precision using neuronavigation [16].”
BackgroundPhilip, N. S., Barredo, J., Aiken, E., & Carpenter, L. L. (2017) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.10.007 · Cited by 136
“Following calibration, a course of TMS is delivered to the prefrontal cortex at 120% of MT on a daily basis for up to 30 (or more) sessions, often followed by a taper phase (for a review of clinical TMS see (23, 24)).”
MethodSelf-citationReliability of targeting methods in TMS for depression: Beam F3 vs. 5.5 cm
Trapp, N. T., Bruss, J., Johnson, M. K., Uitermarkt, B. D., Garrett, L., Heinzerling, A., Wu, C., Koscik, T. R., Eyck, P. T., & Boes, A. D. (2020) · Brain stimulation · doi:10.1016/j.brs.2020.01.010 · Cited by 123
“Repetitive transcranial magnetic stimulation (TMS) is an effective treatment for major depressive disorder when targeted at the left prefrontal cortex [1].”
BackgroundMethodZhang, W., Deng, B., Xie, F., Zhou, H., Guo, J., Jiang, H., Sim, A., Tang, B., & Wang, Q. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101589 · Cited by 129
Transcranial Magnetic Stimulation in Alzheimer’s Disease: Are We Ready?
Weiler, M., Stieger, K. C., Long, J. M., & Rapp, P. R. (2019) · eNeuro · doi:10.1523/eneuro.0235-19.2019 · Cited by 122
“Challenges in assessing rTMS effects in AD As noted earlier, TMS is approved for the treatment of medication-resistant depression (McClintock et al., 2018; Kaster et al., 2019).”
BackgroundAccelerated theta burst stimulation for the treatment of depression: a randomised controlled trial
Chen, L., Thomas, E. H. X., Kaewpijit, P., Miljevic, A., Hughes, R., Hahn, L., Kato, Y., Gill, S., Clarke, P., Ng, F., et al. (2021) · Brain Stimulation · doi:10.1016/j.brs.2021.07.018 · Cited by 105
“In conclusion, this study provides evidence that accelerated bilateral TBS is effective and safe in the treatment of TRD. Bilateral sequential cTBS/iTBS did not infer superior antidepressant effect over left unilateral 10 Hz rTMS.”
BackgroundInfluentialNguyen, T. D., Hieronymus, F., Lorentzen, R., McGirr, A., & Østergaard, S. D. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.10.013 · Cited by 104
Bulteau, S., Laurin, A., Péré, M., Fayet, G., Thomas-Ollivier, V., Deschamps, T., Auffray-Calvier, E., Bukowski, N., Vanelle, J., Sebille, V., et al. (2022) · Brain stimulation · doi:10.1016/j.brs.2022.05.011 · Cited by 111
“In parallel, within the last decade, repetitive transcranial magnetic stimulation (rTMS) has assumed an increasingly important role in the depression treatment armamentarium [6,7].”
Transcranial magnetic stimulation (TMS) for geriatric depression
Cappon, D., den Boer, T., Jordan, C., Yu, W., Metzger, E., & Pascual-Leone, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101531 · Cited by 97
Latorre, A., Rocchi, L., Berardelli, A., Bhatia, K. P., & Rothwell, J. C. (2019) · Movement Disorders · doi:10.1002/mds.27705 · Cited by 100
Trapp, N. T., Purgianto, A., Taylor, J. J., Singh, M. K., Oberman, L. M., Mickey, B. J., Youssef, N. A., Solzbacher, D., Zebley, B., Cabrera, L. Y., et al. (2025) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.12.015 · Cited by 89
Self-citationInduction and Quantification of Excitability Changes in Human Cortical Networks
Keller, C. J., Huang, Y., Herrero, J. L., Fini, M. E., Du, V. X., Lado, F. A., Honey, C. J., & Mehta, A. D. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1088-17.2018 · Cited by 91
Mula, M., Brodie, M. J., de Toffol, B., Guekht, A. B., Hečimović, H., Kanemoto, K., Kanner, A. M., Teixeira, A. L., & Wilson, S. J. (2021) · Epilepsia · doi:10.1111/epi.17140 · Cited by 93
Ameis, S. H., Blumberger, D. M., Croarkin, P. E., Mabbott, D., Lai, M., Desarkar, P., Szatmári, P., & Daskalakis, Z. J. (2020) · Brain stimulation · doi:10.1016/j.brs.2020.01.007 · Cited by 100
“Resting motor threshold (RMT) was determined by a physician 155 not involved in the current study and was blind to treatment assignment(35).”
MethodChu, H., Cheng, C., Liang, C., Chang, W.-H., Juan, C.-H., Huang, Y., Jeng, J., Bai, Y., Tsai, S., Chen, M., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110168 · Cited by 100
Corlier, J., Carpenter, L. L., Wilson, A. C., Tirrell, E., Gobin, A. P., Kavanaugh, B. C., & Leuchter, A. F. (2019) · Brain stimulation · doi:10.1016/j.brs.2019.07.018 · Cited by 88
“Repetitive Transcranial Magnetic Stimulation (rTMS) for treatment of Major Depressive Disorder (MDD) is commonly administered to left dorsolateral prefrontal cortex (DLPFC) at a frequency of 10 Hz [1].”
MethodSelf-citationPan, F., Shen, Z., Jiao, J., Chen, J., Li, S., Lü, J., Duan, J., Wei, N., Shang, D., Hu, S., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1858 · Cited by 92
“As shown in the consensus recom mendations for the clinical application of rTMS in the treatment of depression, administering > 3,000 pulses per session was one of the suggestions with best quality evidence for guiding clinical applica tion of rTMS.(30) Furthermore, standard rTMS that lasted 4–6 weeks with oncedail…”
MethodBlumberger, D. M., Vila-Rodriguez, F., Wang, W., Knyahnytska, Y., Butterfield, M., Noda, Y., Yariv, S., Isserles, M., Voineskos, D., Ainsworth, N. J., et al. (2021) · Brain Stimulation · doi:10.1016/j.brs.2021.09.003 · Cited by 81
“In addition, our trial included TRD patients who had failed more than three antidepressant trials in the current episode and our group found that greater number of antidepressant failures is associated with lower remission rates with once daily rTMS or iTBS [30].”
InfluentialAccelerated Theta Burst Stimulation: Safety, Efficacy, and Future Advancements
Cole, E., O’Sullivan, S. J., Tik, M., & Williams, N. R. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.12.004 · Cited by 79
Magnetic Strategies for Nervous System Control
Christiansen, M. G., Senko, A. W., & Anikeeva, P. (2019) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070918-050241 · Cited by 83
“TMS has shown promise for treating depression (Brunoni et al. 2017, McClintock et al. 2018) and Annu Rev Neurosci.”
MethodVoigt, J. D., Carpenter, L. L., & Leuchter, A. F. (2019) · BMC Psychiatry · doi:10.1186/s12888-018-1989-z · Cited by 91
“[10] shows that while there was not a statistically significant difference in outcomes between non-treatment/treatment resistant subgroups, there was also an identified trend favoring the clinical efficacy of rTMS in patients who have undergone ≤1 failed medication trial.”
BackgroundMethodResultInfluentialSelf-citationFilipčić, I., Filipčić, I. Š., Milovac, Ž., Sučić, S., Gajšak, T., Ivezić, E., Bašić, S., Bajić, Ž., & Heilig, M. A. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.020 · Cited by 85
Theta burst stimulation for depression: a systematic review and network and pairwise meta-analysis
Kishi, T., Ikuta, T., Sakuma, K., Hatano, M., Matsuda, Y., Wilkening, J., Goya-Maldonado, R., Tik, M., Williams, N. R., Kito, S., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02630-5 · Cited by 74
“Repetitive transcranial magnetic stimulation (rTMS) is recommended as treatment for individuals with pharmacological treatment-resistant depression (TRD) according to evidence [1 – 3].”
Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges
Wu, C., Yang, L., Feng, S., Zhu, L., Yang, L., Liu, T. C., & Duan, R. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00216-8 · Cited by 77
“4 Department of Neuroscience and Regenerative Medicine, Medi‑ cal College of Georgia, Augusta University, Augusta, GA 30912, USA.”
BackgroundInfluentialMüller, H., Moeller, S., Lücke, C., Lam, A. P., Braun, N., & Philipsen, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00239 · Cited by 80
“These findings indicate that rTMS should be considered prior to pursuing ECT or as an add-on strategy and that patients who have not responded to ECT are unlikely to respond to rTMS treatment sessions alone (McClintock et al., 2018).”
BackgroundTrevizol, A. P., Downar, J., Vila-Rodriguez, F., Thorpe, K. E., Daskalakis, Z. J., & Blumberger, D. M. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100349 · Cited by 70
Zhang, J., Raya, J., Morfini, F., Urban, Z., Pagliaccio, D., Yendiki, A., Auerbach, R. P., Bauer, C. C. C., & Whitfield, S. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02032-z · Cited by 72
“By comparison, randomized controlled clinical trials for TMS — where a treatment target is typically not functionally localized — demonstrates a response rate between 15 – 37% and a remission rate between 14 – 30% [88].”
BackgroundShi, Y., Song, R., Wang, Z., Zhang, H., Zhu, J., Yue, Y., Zhao, Y., & Zhang, Z. (2021) · eBioMedicine · doi:10.1016/j.ebiom.2021.103337 · Cited by 65
“The resting motor threshold (RMT) was determined at each visit according to standard clinical practice [44].”
BackgroundMethodTranscranial Magnetic Stimulation for Adolescent Depression
Croarkin, P. E., & MacMaster, F. P. (2019) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2018.07.003 · Cited by 65
Cardenas, V. A., Bhat, J. V., Horwege, A. M., Ehrlich, T. J., Lavacot, J. A., Mathalon, D. H., Glover, G. H., Roach, B. J., Badran, B. W., Forman, S. D., et al. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.11.008 · Cited by 73
“In the absence of MRI-guided neuronavigation, targeting at the EEG F3 electrode location [34] or the Beam F3 simplified scalp tracing scheme [35] are recommended [36], as these techniques make simple adjustments for head size [37].”
MethodSelf-citationAddressing the Causality Gap in Human Psychiatric Neuroscience
Etkin, A. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3610 · Cited by 65
Transcranial Magnetic Stimulation (TMS) in the Elderly
Iriarte, I. G., & George, M. S. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0866-2 · Cited by 72
Self-citationZibman, S., Pell, G. S., Barnea‐Ygael, N., Roth, Y., & Zangen, A. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.06.009 · Cited by 66
Cash, R. F. H., Cocchi, L., Anderson, R., Rogachov, A., Kucyi, A., Barnett, A. J., Zalesky, A., & Fitzgerald, P. B. (2019) · Human Brain Mapping · doi:10.1002/hbm.24725 · Cited by 70
“Treatment is time-intensive (>4 weeks of daily rTMS), costly (USD $4,000–12,000; McClintock et al., 2018) and often has limited availability resulting in a considerable and unnecessary burden for nonresponders (NRs) and clinics.”
BackgroundCarpenter, L. L., Conelea, C. A., Tyrka, A. R., Welch, E. S., Greenberg, B. D., Price, L. H., Niedzwiecki, M. J., Yip, A. G., Barnes, J. L., & Philip, N. S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.009 · Cited by 62
“5 Hz stimulation using an H-coil produced significant improvement in social anxiety and social relatedness when compared with sham in an autism sample (Enticott et al., 2014).”
Self-citationCarpenter, L. L., Aaronson, S., Hutton, T. M., Mina, M., Pages, K. P., Verdoliva, S., West, W. S., & Sackeïm, H. A. (2020) · Brain stimulation · doi:10.1016/j.brs.2020.12.003 · Cited by 65
“5 cm rule,” to the “Beam F3 method” or by placement of a simple EEG Brainnet to mark F3 could have been influenced by published consensus recommendations in 2018 [4] which were subsequently disseminated in national TMS training courses.”
Self-citationZhao, H., Jiang, C., Zhao, M., Yang, Y., Liang, Y., Li, Y., Luan, H., Zhang, S., Xu, P., Chen, X., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.12.013 · Cited by 69
Jodoin, V. D., Miron, J., & Lespérance, P. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.10.019 · Cited by 70
Glutamatergic System in Depression and Its Role in Neuromodulatory Techniques Optimization
Khoodoruth, M. A. S., Estudillo‐Guerra, M. A., Pacheco‐Barrios, K., Nyundo, A., Chapa-Koloffon, G., & Ouanes, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.886918 · Cited by 73
“In case of poor response to HF-rTMS, LF-TMS can be especially advantageous and safe when there is high risk of seizures and poor tolerability to pain (117, 122).”
BackgroundLarge-scale lesion symptom mapping of depression identifies brain regions for risk and resilience
Trapp, N. T., Bruss, J., Manzel, K. W., Grafman, J. H., Tranel, D., & Boes, A. D. (2022) · Brain · doi:10.1093/brain/awac361 · Cited by 74
Chen, L., Klooster, D., Tik, M., Thomas, E. H. X., Downar, J. H., Fitzgerald, P. B., Williams, N., & Baeken, C. (2023) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000364 · Cited by 67
Modak, A., & Fitzgerald, P. B. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.1907710 · Cited by 56
“…used TMS protocol involves the delivery of either 10Hz TMS to the left dlPFC although other protocols, such as applying 1Hz TMS to the right dlPFC (McClintock et al. 2018), or the use of theta-burst stimulation (TBS), which delivers 50Hz bursts of TMS at a frequency of 5 Hz (Chen et al. 2019),…”
BackgroundMethodTikka, S. K., Siddiqui, M. A., Garg, S., Pattojoshi, A., & Gautam, M. (2023) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_492_22 · Cited by 62
“[10] It is important to note that participants who have received rTMS sessions safely in the past are at less risk than those receiving rTMS newly.”
InfluentialRepetitive Transcranial Magnetic Stimulation in Youth With Treatment Resistant Major Depression
MacMaster, F. P., Croarkin, P. E., Wilkes, T. C., McLellan, Q., Langevin, L. M., Jaworska, N., Swansburg, R. M., Jasaui, Y., Zewdie, E., Ciechanski, P., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00170 · Cited by 57
Guinot, M., Maindet, C., Hodaj, H., Hodaj, E., Bachasson, D., Baillieul, S., Cracowski, J., & Launois, S. H. (2019) · Arthritis Care & Research · doi:10.1002/acr.24118 · Cited by 59
“Indeed, 4 to 6 weeks (a 5-week session) are recommended for depression, while antidepressant effects of rTMS usually appear as soon as 2 or 3 weeks (18).”
BackgroundRen, J., Ren, W., Zhou, Y. C., Dahmani, L., Duan, X., Fu, X., Wang, Y., Pan, R., Zhao, J., Zhang, P., et al. (2023) · Brain stimulation · doi:10.1016/j.brs.2023.08.023 · Cited by 60
“The RMT was measured as the minimal stimulation intensity that evoked a muscle contraction in the first dorsal interosseous muscle of the hand contralateral to the stimulated hemisphere in more than five of ten consecutive trials [40].”
Pink, A. E., Williams, C., Alderman, N., & Stoffels, M. (2019) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2019.1706585 · Cited by 50
Kim, W. S., Rosselin, C., Amatya, B., Hafezi, P., & Khan, F. (2020) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-2637 · Cited by 63
Grosshagauer, S., Woletz, M., Vasileiadi, M., Linhardt, D., Nohava, L., Schuler, A., Windischberger, C., Williams, N., & Tik, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02535-3 · Cited by 63
“Current treatment protocols perform stimulation during rest/unconstrained thoughts, i.e. the patients are asked to stay awake and to avoid motion [33].”
BackgroundIntracortical Dynamics Underlying Repetitive Stimulation Predicts Changes in Network Connectivity
Huang, Y., Hajnal, B., Entz, L., Fabó, D., Herrero, J. L., Mehta, A. D., & Keller, C. J. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0535-19.2019 · Cited by 55
Trapp, N. T., Pace, B., Neisewander, B., Eyck, P. T., & Boes, A. D. (2023) · Brain stimulation · doi:10.1016/j.brs.2023.09.006 · Cited by 58
“More recent studies have suggested use of a “ 5.5 cm ” or “ 6 cm ” method to more reliably target the left DLPFC [6].”
MethodResultInfluentialMendlowitz, A. B., Shanbour, A., Downar, J. H., Vila‐Rodriguez, F., Daskalakis, Z. J., Isaranuwatchai, W., & Blumberger, D. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222546 · Cited by 58
Does non-invasive brain stimulation modulate emotional stress reactivity?
Smits, F., Schutter, D. J. L. G., van Honk, J., & Geuze, E. (2020) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsaa011 · Cited by 57
“Moreover, for therapeutic use in affective disorders, a sequence of 20–30 sessions is recommended (McClintock et al., 2018).”
BackgroundXu, X., Dai, J., Chen, Y., Liu, C., Xin, F., Zhou, X., Zhou, F., Stamatakis, E. A., Yao, S., Luo, L., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00868-5 · Cited by 56
Williams, L. M., Coman, J. T., Stetz, P. C., Walker, N. C., Kozel, F. A., George, M. S., Yoon, J. H., Hack, L. M., Madore, M. R., Lim, K. O., et al. (2021) · BMC Psychiatry · doi:10.1186/s12888-020-03030-z · Cited by 54
“This approach is recommended by the National Network of Depression Centers [78] when frameless stereotaxy is unavailable or impractical.”
MethodSelf-citationCurrent Updates on Newer Forms of Transcranial Magnetic Stimulation in Major Depression
Cheng, C., Li, C., & Tsai, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_18 · Cited by 52
Vergallito, A., Gallucci, A., Pisoni, A., Punzi, M., Caselli, G., Ruggiero, G. M., Sassaroli, S., & Lauro, L. J. R. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.210050 · Cited by 66
Xu, Y., Qiu, Z., Zhu, J., Liu, J., Wu, J., Tao, J., & Chen, L. (2019) · BMC Neuroscience · doi:10.1186/s12868-018-0484-2 · Cited by 52
McClintock, S. M., Martin, D. M., Lisanby, S. H., Alonzo, A., McDonald, W. M., Aaronson, S. T., Husain, M. M., O’Reardon, J. P., Weickert, C. S., Mohan, A., et al. (2020) · Depression and Anxiety · doi:10.1002/da.22988 · Cited by 54
“, electroconvulsive therapy [ECT], vagus nerve stimulation, transcranial magnetic stimulation), may be beneficial; however, given limited response and remission rates and possible adverse treatment‐ associated side effects, the neuropsychiatric field is in need of more effective antidepressant therapies (Collins, Pate…”
BackgroundSelf-citationCervigni, M., Onesti, E., Ceccanti, M., Gori, M. C., Tartaglia, G., Campagna, G., Panico, G., Vacca, L., Cambieri, C., Libonati, L., et al. (2018) · Neurourology and Urodynamics · doi:10.1002/nau.23718 · Cited by 61
“The BDI was analyzed because rTMS is also used as a safe and effective clinical application in the treatment of major depressive disorder.(43) Repetitive TMS over cortical motor areas induces a plasticity process mediated by the activation of NMDA receptors and AMPA receptors as well as by the modulation of calcium cu…”
MethodNi, H., Chen, Y., Chao, Y., Wu, C., Wu, Y., Liang, S. H., Chin, W., Chou, T., Gau, S. S., Huang, Y., et al. (2021) · Autism · doi:10.1177/1362361321990534 · Cited by 58
Tseng, P., Jeng, J., Zeng, B., Stubbs, B., Carvalho, A. F., Brunoni, A. R., Su, K., Tu, Y., Wu, Y., Chen, T., et al. (2021) · Addiction · doi:10.1111/add.15624 · Cited by 55
Minzenberg, M., & Leuchter, A. F. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.067 · Cited by 55
Zuo, C., Cao, H., Ding, F., Zhao, J., Huang, Y., Guo, L., Huang, S., Jiang, H., Jiang, Y., & Wang, F. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.03.018 · Cited by 53
Sciortino, D., Pigoni, A., Delvecchio, G., Maggioni, E., Schiena, G., & Brambilla, P. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.001 · Cited by 52
Adams, T. G., Cisler, J. M., Kelmendi, B., George, J. R., Kichuk, S. A., Averill, C. L., Anticevic, A., Abdallah, C. G., & Pittenger, C. (2021) · Depression and Anxiety · doi:10.1002/da.23212 · Cited by 48
Godfrey, K. E. M., Muthukumaraswamy, S. D., Stinear, C. M., & Hoeh, N. R. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111377 · Cited by 49
Sabé, M., Sulstarova, A., Chen, C., Hyde, J., Poulet, E., Aleman, A., Downar, J. H., Brandt, V. C., Mallet, L., Sentissi, O., et al. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105300 · Cited by 54
Seizure risk with repetitive TMS: Survey results from over a half-million treatment sessions
Taylor, J. J., Newberger, N. G., Stern, A. P., Phillips, A., Feifel, D., Betensky, R. A., & Press, D. Z. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.05.012 · Cited by 55
“Seizures have been recognized as adverse events of transcranial magnetic stimulation (TMS) since the corticospinal tract experiments of the 1980s (1-5).”
BackgroundInteroception and alcohol: Mechanisms, networks, and implications
Lovelock, D. F., Tyler, R. E., & Besheer, J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108807 · Cited by 48
Fukuda, A. M., Kang, J. W. D., Gobin, A. P., Tirrell, E., Kokdere, F., & Carpenter, L. L. (2021) · Brain and Behavior · doi:10.1002/brb3.2329 · Cited by 49
“In pharmacotherapy trials, anhedonia has been shown to be a predictor of inferior outcomes (McMakin et al., 2012; Uher et al., 2012).”
BackgroundSelf-citationTreating Depression With Repetitive Transcranial Magnetic Stimulation: A Clinician’s Guide
Chen, L., Fukuda, A. M., Jiang, S., Leuchter, M. K., van Rooij, S. J. H., Widge, A. S., McDonald, W. M., & Carpenter, L. L. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240859 · Cited by 49
Self-citationLiu, C. S., Rau, A., Gallagher, D., Rajji, T. K., Lanctôt, K. L., & Herrmann, N. (2017) · Neurodegenerative Disease Management · doi:10.2217/nmt-2017-0021 · Cited by 46
Neacsiu, A. D., Luber, B. M., Davis, S. W., Bernhardt, E. R., Strauman, T. J., & Lisanby, S. H. (2018) · Journal of Ect · doi:10.1097/yct.0000000000000545 · Cited by 46
Self-citationGe, R., Downar, J. H., Blumberger, D. M., Daskalakis, Z. J., Lam, R. W. M., & Vila‐Rodriguez, F. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.012 · Cited by 49
Metadata
- Authors
- McClintock, S. M., Reti, I. M., Carpenter, L. L., McDonald, W. M., Dubin, M., Taylor, S. F., Cook, I. A., O’Reardon, J., Husain, M. M., Wall, C., Krystal, A. D., Sampson, S. M., Morales, O., Nelson, B. G., Latoussakis, V., George, M. S., Lisanby, S. H., & on behalf of both the National Network of Depression Centers rTMS Task Group and the American Psychiatric Association Council on Research Task Force on Novel Biomarkers and Treatments
- Affiliations
- Duke University (US)
- Johns Hopkins University (US)
- Butler Hospital (US)
- Emory University (US)
- Weill Cornell Medicine (US)
- University of Michigan (US)
- University of California, Los Angeles (US)
- American Psychiatric Association (US)
- Mayo Clinic (US)
- Harvard University (US)
- University of Minnesota (US)
- Medical University of South Carolina (US)
- Corresponding author
- McClintock, Shawn M.
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2018-02-21
- Volume
- 79
- Issue
- 1
- Pages
- 35-48
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC5846193
- OpenAlex
- W2617605873
- Cited by
- 693
- References
- 120
- Citations by year
- 2026: 77 · 2025: 94 · 2024: 108 · 2023: 82 · 2022: 85 · 2021: 98 · 2020: 66 · 2019: 54 · 2018: 22
- FWCI
- 20.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR002384)
- National Institute of Mental Health (K23MH087739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- repetitive transcranial magnetic stimulation, major depressive disorder, depression treatment, expert consensus recommendations, antidepressant treatment
- MeSH terms
- Contraindications, Major Depressive Disorder, Humans, Transcranial Magnetic Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.